Automated quantitative insights, DCF fair value shifts, and catalyst commentary.
Current price stands at $187.05 with a Health Score of 8/10. P/E ratio is 148.4x. Free Cash Flow yield sits at 0.5%. The Python signal summary shows 4 of 7 dimensions bullish, 2 cautious, and 1 neutral, which lands the composite view squarely in mixed territory.
Current price stands at $15.72 with a Health Score of 5/10. P/E ratio is 30.8x. Free Cash Flow yield sits at -19.7%. Only 2 of 7 scored signals are bullish, against 4 cautious and 1 neutral, and that distribution anchors the verdict firmly on the cautious side.
Current price stands at $229.57 with a Health Score of 8/10. P/E ratio is 20.9x. Free Cash Flow yield sits at 7.6%. The pre-scored signal summary shows 3 of 6 dimensions bullish, 3 neutral, and 0 cautious, with the suggested verdict of NEUTRAL — and the data supports that balanced read.
Current price stands at $456.19 with a Health Score of 8/10. P/E ratio is 1.1x. Free Cash Flow yield sits at 41.9%. Six of the seven scored signals are bullish, with one neutral and none cautious, and the Python suggested verdict is BULLISH.
Current price stands at $359.33 with a Health Score of 8/10. P/E ratio is 30.5x. Free Cash Flow yield sits at 3.2%. The Python-scored signal summary shows 2 of 7 bullish signals, 2 of 7 cautious signals, and 3 of 7 neutral signals — a genuinely mixed picture that supports a neutral stance.
Current price stands at $330.83 with a Health Score of 6/10. P/E ratio is 14.2x. Free Cash Flow yield sits at -16.8%. Only 2 of 7 scored signals are bullish, 2 are cautious, and 3 are neutral, which anchors the verdict firmly in neutral territory.
Current price stands at $69.58 with a Health Score of 6/10. P/E ratio is 21.5x. Free Cash Flow yield sits at 3.3%. The Python-calculated signal summary shows 3 of 7 dimensions bullish, 2 cautious, and 2 neutral, with a suggested verdict of NEUTRAL — a balanced picture that reflects genuine cross-currents in the data.
Current price stands at $611.76 with a Health Score of 8/10. P/E ratio is 155.3x. Free Cash Flow yield sits at 0.7%. 4 of 7 scored signals are bullish, 2 are cautious, and 1 is neutral, which is why the Python summary lands on a NEUTRAL verdict and why I am aligning with it.
Current price stands at $354.81 with a Health Score of 5/10. P/E ratio is 332.9x. Free Cash Flow yield sits at 0.4%. The Python signal summary shows 3 of 7 scored signals bullish, 3 cautious, and 1 neutral, which anchors the neutral verdict.
Current price stands at $725.18 with a Health Score of 8/10. P/E ratio is 27.0x. Free Cash Flow yield sits at 2.5%. The Python signal summary shows 4 of 7 scored dimensions bullish, 2 cautious, and 1 neutral, which anchors the neutral verdict.
Current price stands at $249.15 with a Health Score of 8/10. P/E ratio is 19.8x. Free Cash Flow yield sits at 0.3%. The Python-calculated signal summary shows 4 of 7 dimensions bullish, 2 neutral, and 1 cautious, which supports a neutral overall stance.
Current price stands at $344.08 with a Health Score of 8/10. P/E ratio is 17.1x. Free Cash Flow yield sits at 1.7%. The Python-calculated signal summary shows 4 of 6 scored signals are bullish, with 2 neutral and 0 cautious, anchoring the constructive view.
Current price stands at $228.38 with a Health Score of 9/10. P/E ratio is 28.7x. Free Cash Flow yield sits at 1.8%. 5 of 7 scored signals are bullish, 1 is cautious, and 1 is neutral, with the Python suggested verdict also BULLISH.
Current price stands at $512.9 with a Health Score of 8/10. P/E ratio is 28.5x. Free Cash Flow yield sits at 1.8%. 5 of 7 scored signals are bullish, with only insider activity flagged as cautious and technicals neutral.
Current price stands at $333.02 with a Health Score of 8/10. P/E ratio is 38.1x. Free Cash Flow yield sits at 2.0%. The Python signal summary shows 2 of 6 scored signals bullish, 0 cautious, and 4 neutral, with a suggested verdict of NEUTRAL — and the data supports that balanced read.
Current price stands at $509.77 with a Health Score of 8/10. P/E ratio is 12.8x. Free Cash Flow yield sits at 2.3%. Five of the seven scored signals are bullish, one is cautious, and one is neutral, giving a clear majority in favour of the constructive case.
Current price stands at $163.54 with a Health Score of 7/10. P/E ratio is 21.1x. Free Cash Flow yield sits at 3.5%. The Python signal summary shows 3 of 7 dimensions bullish, 3 neutral, and 1 cautious, which aligns with a genuinely mixed picture rather than a clear directional call.
Current price stands at $106.73 with a Health Score of 6/10. P/E ratio is 38.5x. Free Cash Flow yield sits at 1.8%. Only 2 of 7 scored signals are bullish, with 3 cautious and 2 neutral, and the Python-suggested verdict is CAUTIOUS — a call I am aligning with.
Current price stands at $1152.93 with a Health Score of 7/10. P/E ratio is 38.6x. Free Cash Flow yield sits at 0.6%. The Python-scored signal summary shows 3 of 7 dimensions bullish, 2 cautious, and 2 neutral, with the suggested verdict being NEUTRAL — and the data supports that balanced assessment.
Current price stands at $357.61 with a Health Score of 8/10. P/E ratio is 44.4x. Free Cash Flow yield sits at 1.6%. Three of seven scored signals are bullish, two are cautious, and two are neutral, which anchors this as a genuinely mixed picture rather than a clear directional call.
Current price stands at $265.05 with a Health Score of 6/10. P/E ratio is 10.2x. Free Cash Flow yield sits at 14.2%. The pre-scored signal summary shows 3 of 7 dimensions as bullish, 2 as cautious, and 2 as neutral, supporting a balanced assessment rather than a directional call.
Current price stands at $232.98 with a Health Score of 8/10. P/E ratio is 32.4x. Free Cash Flow yield sits at 2.7%. The pre-scored signal summary shows 4 of 7 dimensions are bullish, 1 cautious, and 2 neutral, which supports the suggested NEUTRAL verdict.
Current price stands at $177.46 with a Health Score of 7/10. P/E ratio is 23.3x. Free Cash Flow yield sits at 6.6%. The signal summary shows a split picture: 2 bullish signals (cash flow, analyst consensus), 2 neutral signals (valuation, growth), and 1 cautious signal (debt).
Current price stands at $31.3 with a Health Score of 6/10. P/E ratio is 12.7x. Free Cash Flow yield sits at 3.3%. 4 of 6 scored signals are bullish, supporting a positive directional view.
Current price stands at $89.85 with a Health Score of 8/10. P/E ratio is 12.9x. Free Cash Flow yield sits at 13.6%. 3 of 5 scored signal dimensions are bullish, with 2 neutral and 0 cautious, supporting a constructive overall view.